Air Force General Hospital, Beijing, People's Republic of China
Lung cancer patient outcome after stereotactic body radiation therapy may be promising
Published in Medical Device Business Week, November 1st, 2006
According to a recent article published in the International Journal of Radiation Oncology Biology Physics, scientists in the People's Republic of China conducted a study "to evaluate the efficacy and toxicity of hypofractionated stereotactic body radiotherapy in patients with Stage I/II non-small-cell lung cancer. Forty-three patients with inoperable Stage I/II non-small-cell lung cancer underwent treatment prospectively using the stereotactic gamma-ray whole-body therapeutic system (body gamma-knife...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week
More Articles from Medical Device Business Week
- Accentia Biopharmaceuticals
Accentia enters into definitive deal for a $25 million financing - Acorda Therapeutics
Acorda Therapeutics announces $31.5 million financing - Affinergy
Affinergy awarded $1.8 million grant for implant coatings - Arrow International
Arrow International reports 13% increase in sales - Auriga Laboratories
Auriga reports revenue guidance forecast of $26.4 million - Avant Immunotherapeutics
Avant Immunotherapeutics receives grant to develop, manufacture Ty800 with VitriLife - More from this issue of Medical Device Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
